^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody

    Company:
    Roche
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    almost2years
    Roche launches two new antibodies to identify key clinical mutations in patients with brain cancer (Roche Press Release)
    "Roche...announced today the launch of the IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody and the ATRX Rabbit Polyclonal Antibody to identify mutation status in patients diagnosed with brain cancer....The two tests are now available in the US. They will likely be available in other non-CE markets later this year and in countries that accept the CE mark in 2024."
    Launch US
    |
    ATRX Rabbit Polyclonal Antibody • IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody